Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334706778> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2334706778 endingPage "S327" @default.
- W2334706778 startingPage "S327" @default.
- W2334706778 abstract "Prognosis is extremely poor for AML patients who relapse after allogeneic stem cell transplantation. Donor Lymphocyte infusions (DLI) can be used to salvage these patients with complete response rates reported to be 10-15% with an associated 40-60% chance of developing clinically significant GVHD. The mechanism by which DLI results in clinical responses is thought to be a T-cell mediated process. Data suggest that DLI normalizes the T-cell receptor repertoire and expands the anti-leukemic cell population. Hypomethylating agents, which appear to foster the graft versus leukemia phenomenon, were combined with DLI in attempt to enhance the graft versus leukemia effect. We report ten AML patients who received Decitabine +/- Etoposide with incremental DLI as salvage after relapse from allogeneic stem cell transplantation during the years 2007-2010. These patients were between the ages of 26- 73 years. Six patients had de novo AML. Three patients were transformed from MDS, and one from essential thrombocythemia. Eight patients had reduced intensity conditioning regimens. Two patients received a fully ablative preparative regimen. Average time to progression post transplant was 17 months. Patients received Decitabine at 20mg/m2 for 5 - 10 days, some in combination with Etoposide for 3-5days for disease control. Patients received 1-4 courses of treatment approximately every 28 days with DLI between days 14-21. Two patients who progressed while receiving Decitabine/Etoposide received Clofarabine at 20-52mg/m2 for 5 days, with subsequent DLI. Cell dose ranged from 1.27 to 31.7 CD3+ cells / kg. Two patients received a mobilized DLI. Six out of ten patients regained full chimerism. One patient who relapsed with extra medullary disease never lost his graft. Seven out of ten patients achieved a complete remission. Only one patient developed Grade 2 GVHD of the skin. Overall survival in these patients after relapse from allogeneic transplantation was 10.8 months. The combination of Decitabine and DLI is a well tolerated outpatient therapeutic option for patients with relapsed AML post allogeneic stem cell transplantation. The majority of patients regained full chimerism and achieved complete remission with little or no GVHD." @default.
- W2334706778 created "2016-06-24" @default.
- W2334706778 creator A5000429690 @default.
- W2334706778 creator A5029148665 @default.
- W2334706778 creator A5034948336 @default.
- W2334706778 creator A5073040359 @default.
- W2334706778 creator A5077726286 @default.
- W2334706778 date "2012-02-01" @default.
- W2334706778 modified "2023-10-14" @default.
- W2334706778 title "Decitabine in Combination with Donor Lymphocyte Infusion as Salvage Therapy for Relapsed AML Post-Allogeneic Stem Cell Transplantation" @default.
- W2334706778 doi "https://doi.org/10.1016/j.bbmt.2011.12.322" @default.
- W2334706778 hasPublicationYear "2012" @default.
- W2334706778 type Work @default.
- W2334706778 sameAs 2334706778 @default.
- W2334706778 citedByCount "0" @default.
- W2334706778 crossrefType "journal-article" @default.
- W2334706778 hasAuthorship W2334706778A5000429690 @default.
- W2334706778 hasAuthorship W2334706778A5029148665 @default.
- W2334706778 hasAuthorship W2334706778A5034948336 @default.
- W2334706778 hasAuthorship W2334706778A5073040359 @default.
- W2334706778 hasAuthorship W2334706778A5077726286 @default.
- W2334706778 hasBestOaLocation W23347067781 @default.
- W2334706778 hasConcept C104317684 @default.
- W2334706778 hasConcept C126322002 @default.
- W2334706778 hasConcept C141071460 @default.
- W2334706778 hasConcept C143998085 @default.
- W2334706778 hasConcept C150194340 @default.
- W2334706778 hasConcept C185592680 @default.
- W2334706778 hasConcept C190727270 @default.
- W2334706778 hasConcept C2776694085 @default.
- W2334706778 hasConcept C2777198975 @default.
- W2334706778 hasConcept C2778041864 @default.
- W2334706778 hasConcept C2778119113 @default.
- W2334706778 hasConcept C2778461978 @default.
- W2334706778 hasConcept C2779695342 @default.
- W2334706778 hasConcept C2779972918 @default.
- W2334706778 hasConcept C2780235182 @default.
- W2334706778 hasConcept C2780775027 @default.
- W2334706778 hasConcept C2781413609 @default.
- W2334706778 hasConcept C28328180 @default.
- W2334706778 hasConcept C2911091166 @default.
- W2334706778 hasConcept C54355233 @default.
- W2334706778 hasConcept C55493867 @default.
- W2334706778 hasConcept C71924100 @default.
- W2334706778 hasConcept C86803240 @default.
- W2334706778 hasConcept C90924648 @default.
- W2334706778 hasConceptScore W2334706778C104317684 @default.
- W2334706778 hasConceptScore W2334706778C126322002 @default.
- W2334706778 hasConceptScore W2334706778C141071460 @default.
- W2334706778 hasConceptScore W2334706778C143998085 @default.
- W2334706778 hasConceptScore W2334706778C150194340 @default.
- W2334706778 hasConceptScore W2334706778C185592680 @default.
- W2334706778 hasConceptScore W2334706778C190727270 @default.
- W2334706778 hasConceptScore W2334706778C2776694085 @default.
- W2334706778 hasConceptScore W2334706778C2777198975 @default.
- W2334706778 hasConceptScore W2334706778C2778041864 @default.
- W2334706778 hasConceptScore W2334706778C2778119113 @default.
- W2334706778 hasConceptScore W2334706778C2778461978 @default.
- W2334706778 hasConceptScore W2334706778C2779695342 @default.
- W2334706778 hasConceptScore W2334706778C2779972918 @default.
- W2334706778 hasConceptScore W2334706778C2780235182 @default.
- W2334706778 hasConceptScore W2334706778C2780775027 @default.
- W2334706778 hasConceptScore W2334706778C2781413609 @default.
- W2334706778 hasConceptScore W2334706778C28328180 @default.
- W2334706778 hasConceptScore W2334706778C2911091166 @default.
- W2334706778 hasConceptScore W2334706778C54355233 @default.
- W2334706778 hasConceptScore W2334706778C55493867 @default.
- W2334706778 hasConceptScore W2334706778C71924100 @default.
- W2334706778 hasConceptScore W2334706778C86803240 @default.
- W2334706778 hasConceptScore W2334706778C90924648 @default.
- W2334706778 hasIssue "2" @default.
- W2334706778 hasLocation W23347067781 @default.
- W2334706778 hasOpenAccess W2334706778 @default.
- W2334706778 hasPrimaryLocation W23347067781 @default.
- W2334706778 hasRelatedWork W2008662832 @default.
- W2334706778 hasRelatedWork W2273109191 @default.
- W2334706778 hasRelatedWork W2314517044 @default.
- W2334706778 hasRelatedWork W2323896205 @default.
- W2334706778 hasRelatedWork W2348031615 @default.
- W2334706778 hasRelatedWork W2754683296 @default.
- W2334706778 hasRelatedWork W2763210453 @default.
- W2334706778 hasRelatedWork W2770466614 @default.
- W2334706778 hasRelatedWork W3128368052 @default.
- W2334706778 hasRelatedWork W4323773381 @default.
- W2334706778 hasVolume "18" @default.
- W2334706778 isParatext "false" @default.
- W2334706778 isRetracted "false" @default.
- W2334706778 magId "2334706778" @default.
- W2334706778 workType "article" @default.